EFFECTIVENESS OF ILOPROST IN PATIENTS WITH PULMONARY HYPERTENSION FC III - IV BASED ON VORONEZH REGION REGISTRY DATA
https://doi.org/10.38109/2225-1685-2019-2-76-83
Abstract
About the Authors
O. M. KorolkovaRussian Federation
10 Studencheskaya St., Voronezh, 394622
Assistant Professor, Candidate of Medical Sciences, Head of Hospital Therapy and Endocrinology Department
T. M. Chernykh
Russian Federation
10 Studencheskaya St., Voronezh, 394622
Professor, MD, Head of Hospital Therapy and Endocrinology Department
References
1. I.Ye. Chazova, O.A. Arkhipova, T.V. Martynyuk. Pulmonary arterial hypertension in Russia: an analysis of a six-year observation based on National Registry data. Therapeutic archive. 2019; 1 (91): 24 – 30.
2. Martynyuk, T. V. Pulmonary hypertension: diagnosis and treatment. – INA. -Moscow. 2018; 20-24.
3. Pulmonary hypertension. Ed. I.Ye. Chazova, T.V. Martynyuk. Moscow – Practice. 2015; 179 – 192.
4. Korolkova, O.M. Bosentan effectiveness based on the data of the registry of patients with pulmonary hypertension in the Voronezh region. / / Eurasian Heart Journal. 2017; 2: 48 – 50.
Review
For citations:
Korolkova O.M., Chernykh T.M. EFFECTIVENESS OF ILOPROST IN PATIENTS WITH PULMONARY HYPERTENSION FC III - IV BASED ON VORONEZH REGION REGISTRY DATA. Eurasian heart journal. 2019;(2):76-83. https://doi.org/10.38109/2225-1685-2019-2-76-83